Glowing marker dye gives medics a 'second pair of eyes' during prostate cancer surgery
Can't see this email? View it online
   
  Prostate Cancer Prostate Cancer logo  
  The latest prostate cancer news from News Medical  
 Enlarged prostate medications may also decrease the risk for dementia with Lewy bodiesEnlarged prostate medications may also decrease the risk for dementia with Lewy bodies
 
A new study suggests that certain drugs commonly used to treat enlarged prostate may also decrease the risk for dementia with Lewy bodies (DLB).
 
 
 Glowing marker dye gives medics a 'second pair of eyes' during prostate cancer surgeryGlowing marker dye gives medics a 'second pair of eyes' during prostate cancer surgery
 
A glowing marker dye that sticks to prostate cancer cells could help surgeons to remove them in real-time, according to a study funded by Cancer Research UK.
 
   Study alerts transwomen to interpret standard prostate cancer screening guidelines with cautionStudy alerts transwomen to interpret standard prostate cancer screening guidelines with caution
 
UCSF-led study alerts transwomen and physicians to interpret standard screening guidelines with caution.
 
   Can ChatGPT aid in patient education for benign prostate enlargement?Can ChatGPT aid in patient education for benign prostate enlargement?
 
The accuracy and quality of ChatGPT’s responses on male lower urinary tract symptoms indicative of benign prostate enlargement.
 
   WEHI spinout aims to revolutionize the development of cancer drugsWEHI spinout aims to revolutionize the development of cancer drugs
 
Australia has cemented its role in becoming a major player in the next generation of medicines with the launch of Ternarx – a globally competitive biotechnology company dedicated to finding new treatments for hard-to-treat cancers.
 
 Weill Cornell Medicine receives $1.5M grant to predict prostate cancer bone metastasis
 
Weill Cornell Medicine receives $1.5M grant to predict prostate cancer bone metastasisWeill Cornell Medicine received a $1.5 million grant from the U.S. Department of Defense Prostate Cancer Research Program to develop new approaches for predicting the spread of cancer cells to the bone in men with prostate cancer, using tumor samples taken at early stages of the disease.
 
 
 RNA splicing modulation as a precision approach for neuroendocrine cancer treatment
 
RNA splicing modulation as a precision approach for neuroendocrine cancer treatmentNeuroendocrine tumors, including small cell lung cancer and neuroendocrine prostate cancer, are very aggressive with high chances of spreading.
 
 
 First-in-human trial shows safety and efficacy of CAR T cell therapy for advanced prostate cancer
 
First-in-human trial shows safety and efficacy of CAR T cell therapy for advanced prostate cancerTreating prostate cancer with immunotherapy is currently difficult to do.
 
 
 Current screening guidelines could miss prostate cancer in transgender women receiving estrogen
 
Current screening guidelines could miss prostate cancer in transgender women receiving estrogenTransgender women are still at risk for prostate cancer. A new study led by Cedars-Sinai Cancer investigators, published in the peer-reviewed Journal of the American Medical Association, concludes that current screening guidelines could miss early-stage prostate cancer in transgender women on hormone therapy.
 
 
 Pharmacogenomics: A pathway to personalized treatment in prostate cancer
 
Pharmacogenomics: A pathway to personalized treatment in prostate cancerProstate cancer (PC) stands as the second leading cause of death among American men, with about 1 in 8 men diagnosed during their lifetime.
 
 
 AI-powered lesion delineation in prostate cancer PET/CT imaging
 
AI-powered lesion delineation in prostate cancer PET/CT imagingA new editorial paper was published in Oncoscience (Volume 11) on May 20, 2024, entitled, "Deep learning-assisted lesion segmentation in PET/CT imaging: A feasibility study for salvage radiation therapy in prostate cancer."
 
 
 Empowering communities: Penn Medicine's annual mammogram event and health fair
 
Empowering communities: Penn Medicine's annual mammogram event and health fairPenn Medicine will once again join with community partners and Siemens Healthineers to host a free mammogram clinic and community health fair in June, giving the West Philadelphia and Upper Darby communities convenient access to health screenings right in their neighborhoods.